REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $241,000 | -82.7% | 9,567 | -83.2% | 0.00% | -84.2% |
Q2 2020 | $1,395,000 | +64.5% | 57,089 | -0.3% | 0.02% | +46.2% |
Q1 2020 | $848,000 | -8.0% | 57,289 | -0.5% | 0.01% | +44.4% |
Q4 2019 | $922,000 | +15.0% | 57,582 | -6.6% | 0.01% | 0.0% |
Q3 2019 | $802,000 | +0.1% | 61,654 | -0.1% | 0.01% | 0.0% |
Q2 2019 | $801,000 | -19.6% | 61,725 | -2.3% | 0.01% | -18.2% |
Q1 2019 | $996,000 | -21.7% | 63,161 | 0.0% | 0.01% | -31.2% |
Q4 2018 | $1,272,000 | -19.0% | 63,161 | 0.0% | 0.02% | +6.7% |
Q3 2018 | $1,570,000 | -9.5% | 63,161 | 0.0% | 0.02% | -11.8% |
Q2 2018 | $1,734,000 | -10.8% | 63,161 | +0.0% | 0.02% | -15.0% |
Q1 2018 | $1,945,000 | -20.5% | 63,156 | -7.7% | 0.02% | -13.0% |
Q4 2017 | $2,447,000 | +23.6% | 68,459 | -4.7% | 0.02% | +43.8% |
Q3 2017 | $1,980,000 | +26.6% | 71,866 | +21.3% | 0.02% | +23.1% |
Q2 2017 | $1,564,000 | +323.8% | 59,259 | +448.7% | 0.01% | +225.0% |
Q4 2015 | $369,000 | – | 10,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |